
2.45 Delayed Data As of May 17 | ![]() Today’s Change | 2.13 Today|||52-Week Range 28.83 | -57.02% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Indaptus Therapeutics Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +512.24% increase from the last price of 2.45.
The current consensus among 1 polled investment analysts is to Buy stock in Indaptus Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.